

"Specialty CRO advancing clinical research through AI, technology, and 47 years of scientific rigour"
Emmes Group operates as a specialty, tech and AI enabled contract research organisation, conducting clinical trials that bring medical discoveries closer to patients. With over 2,150 Phase I to IV trials in 90 countries, the company supports government agencies, public private partnerships, and biopharma clients across vaccines, infectious disease, ophthalmology, rare disease, and gene therapy. The organisation integrates AI platforms through Veridix, alongside VaxTrials for vaccine research, OptymEdge for ophthalmology imaging, and Essex for informatics. Founded in 1977 and headquartered in Rockville, Maryland, Emmes Group combines decades of scientific rigour with operational tools to deliver faster, more confident health outcomes.


1359
Team Members
1977
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where clinical research accelerates life saving treatments, delivering confident health outcomes for patients and advancing public health through the seamless integration of human expertise, technology, and artificial intelligence.
Emmes Group advances public health and biopharmaceutical innovation by uncovering truth in clinical research through scientific rigour, operational excellence, and deep collaboration with clients and partners.